Clinical Trial

Effects of Four-Cell Galvanic Therapy on Pain and Balance in Diabetic Peripheral Neuropathy

Study acronym: GABATH-DPN
Completed
View on ClinicalTrials.gov →
Summary
This study aims to evaluate the effects of four-cell galvanic bath therapy on pain and balance in patients with diabetic distal symmetric polyneuropathy. Diabetic peripheral neuropathy is a common complication of diabetes that can lead to pain, sensory loss, and impaired balance. In this randomized controlled study, participants received either conventional rehabilitation alone or conventional rehabilitation combined with four-cell galvanic bath therapy. The intervention was applied over a 4-week period. Pain and balance outcomes were assessed using standardized clinical measures. The findings of this study may help determine the effectiveness of galvanic bath therapy as a supportive treatment option in patients with diabetic neuropathy.
Trial Details
NCT Number NCT07590011
Lead Sponsor Ankara Etlik City Hospital
Conditions Diabetic Distal Symmetric Polyneuropathy
Enrollment 66 participants
Start Date 2024-12-24
Primary Completion 2026-03-10 (estimated)
Study Completion 2026-03-10 (estimated)
Updated on ClinicalTrials.gov 2026-05-15